Skip to main content
OTSKY logo

Otsuka Holdings Co., Ltd. (OTSKY) Stock Price & Analysis

Otsuka Holdings Co., Ltd. (OTSKY) — price $37.96 (-2.42%), as of the Nov 18, 2026 trading session; market cap $39.8B.

Educational signal · not a buy or sell recommendation · How to read this

$37.96 −$0.94 (-2.42%) Market Cap $39.8B

Otsuka Holdings Co., Ltd. · OTSKY · Healthcare · Drug Manufacturers - General

Otsuka Holdings Co., Ltd. engages in the management of its group companies which are in the pharmaceuticals business. It operates through the following segments: Pharmaceuticals, Nutraceuticals, Consumer Products, and Others.

Price as of Nov 18, 2026

Key Statistics

No MoonshotScore yet: we have not published a score for this company.

Thousands of the 20,000+ US stocks here carry a MoonshotScore.

Scored companies in the same industry:

  • BIIB · Biogen Inc. · 37 /100
  • GSK · GSK plc · 77 /100
  • SNY · Sanofi · 87 /100

See all scored stocks →

Price & valuation

Dates shown where recorded
MeasureValueAs of
Latest provided price$37.96
Change on the day-2.42%
52-week range$26.11–$40.92
Market capitalisation$39.8B—
Price / earnings (trailing)16.66
Shares traded on the day2.6K
Beta (volatility vs the S&P 500)-0.05

Price & events

Weekly closing price with reported quarters marked Weekly closing price from Oct 17, 2025 to Nov 18, 2026: low $27, high $40, latest $38. $40 $27 high $40 Oct 17, 2025 Nov 18, 2026 · $38 $27Oct 17, 2025$27Oct 31, 2025$27Nov 14, 2025$28Nov 28, 2025$30Dec 12, 2025$29Dec 26, 2025$29Jan 9, 2026$30Jan 23, 2026$30Feb 6, 2026$34Feb 20, 2026$31Mar 6, 2026$33Mar 20, 2026$36Apr 2, 2026$34Apr 17, 2026$36May 1, 2026$35May 15, 2026$37May 29, 2026$32Jun 12, 2026$34Jun 26, 2026$35Jul 10, 2026$34Jul 24, 2026$40Aug 7, 2026$39Aug 21, 2026$38Sep 4, 2026$35Sep 18, 2026$36Oct 2, 2026$39Oct 16, 2026$38Oct 30, 2026$39Nov 13, 2026

Point at or tab to any week for its close.

Other perspectives

Council score for Otsuka Holdings Co. (OTSKY): perspectives

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Legends Council

3 lenses, 3 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Englander-style lens (simulated) Izzy Englander Favorable read
Klarman-style lens (simulated) Seth Klarman Favorable read
Moon AI lens (model) Favorable read

Read on: Nov 20, 2026

Munger's Mindset

Balance Sheet & Valuation · historical

Financial Health Moderate
Margin of Safety Fairly Valued
Profit Margin Moderate
Revenue Growth Moderate
Debt/Equity Strong
ROE Moderate
Gross Margin Strong

Read on: Nov 18, 2026 · older than the 27 hours refresh window; not a current reading

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

On Nov 18, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.

Readings on this page are from Nov 20, 2026, except a card that shows its own read date.

1 · What is it?

What is Otsuka Holdings Co. (OTSKY), and what does it report?

Short answer

Otsuka Holdings Co., Ltd. engages in the management of its group companies which are in the pharmaceuticals business. It operates through the following segments: Pharmaceuticals, Nutraceuticals, Consumer Products, and Others. Healthcare / Drug Manufacturers General Headquarters: 2-9 Kanda-Tsukasamachi, Tokyo, TKY, 101-0048, JP. It employs 37,758 people and is led by Makoto Inoue. The market values it at $39.8B.

3 · Financial strengths and risks

What are the financial strengths and risks for Otsuka Holdings Co. (OTSKY)?

Short answer · as of

The distress and quality screens read Altman Z 5.79 · Piotroski F 8. Trailing ratios: ROE 12.3% · ROA 9.0% · current ratio 2.28 · earnings yield 5.9% · free-cash-flow yield 4.8%.

The records behind this page

Who holds the shares?

Institutional ownership reported through 13F filings.

Tracked investors

Which of the 16 named investors we follow held OTSKY in their latest 13F filing, and what they did against the filing before it.

None of the 16 tracked investors reported OTSKY in their latest 13F filing.

See all tracked investor portfolios

How to read these figures

These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.

What has been published about Otsuka Holdings Co. (OTSKY)?

Read these with our analysis →

OTSKY Healthcare Stock FAQ

Research dated 2026-09-12; the full attribution is under Sources. The last question is answered from this page's own dated data, not from the research.

Why do Otsuka infusions matter to its business mix?

Infusions place treatment delivery alongside the company’s central nervous system, oncology, and infectious-disease medicines. They reinforce that Otsuka’s pharmaceutical activity spans therapeutic products used across distinct care settings rather than a narrow consumer-health portfolio.

What is the OTSKY stock price today?

The last price recorded for Otsuka Holdings Co., Ltd. (OTSKY), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.

Research written by Codex (gpt-5.6-sol) on 2026-09-12. AI-authored analysis; source dates are listed under Sources. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources: the source register lists the 15 figures on this page — 12 from Financial Modeling Prep (FMP) and 3 with no recorded source. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.

Publication details and research sources
Published
Research standards
Methodology · Editorial policy · Corrections

Sources (as of 2026-09-12), by section of the research

  • FAQ: Why do Otsuka infusions matter to its business mix?: Business description
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.